Accendra Health, Inc. (ACH) Tops Q1 EPS by 6c, Misses on Revenue; Reaffirms Guidance

Accendra Health, Inc. (NYSE: ACH) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $627.8 million versus the consensus estimate of $646.24 million.

The company is affirming its prior guidance for net revenue and adjusted EBITDA for the full year 2026.

For earnings history and earnings-related data on Accendra Health, Inc. (ACH) click here.

You May Also Be Interested In

• Regency Centers (REG) Tops Q2 EPS by 2c
• Pathfinder Bancorp (PBHC) Tops Q2 EPS by 42c
• Pinnacle Bank (PBNK) Tops Q2 EPS by 25c